- Q4 2023 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptFeb 29, 2024Earnings
- Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptNov 08, 2023Earnings
- Ginkgo Bioworks Holdings Inc Investor Day TranscriptOct 03, 2023
- Ginkgo Bioworks Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Ginkgo Bioworks Holdings Inc at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 15, 2023
- Q2 2023 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptAug 09, 2023Earnings
- Ginkgo Bioworks Holdings Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Q1 2023 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptMay 10, 2023Earnings
- Codexis Inc, Ginkgo Bioworks Holdings Inc and Twist Bioscience Corp at TD Cowen Health Care Conference- Panel TranscriptMar 06, 2023
- Q4 2022 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptMar 01, 2023Earnings
- Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptNov 14, 2022Earnings
- Q2 2022 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptAug 15, 2022Earnings
- Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call TranscriptJul 25, 2022
- Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call TranscriptJul 25, 2022
- Ginkgo Bioworks Holdings Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Ginkgo Bioworks Holdings Inc at William Blair Growth Stock Conference TranscriptJun 09, 2022
- Q1 2022 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptMay 16, 2022Earnings
- Q4 2021 Ginkgo Bioworks Holdings Inc Earnings Presentation TranscriptMar 28, 2022
- Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptNov 15, 2021Earnings
Q1 2023 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
Good afternoon. I'm Anna Marie Wagner, SVP of Corporate Development at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO. Thanks as always for joining us. We're looking forward to updating you on our progress.
As a reminder, during the presentation today, we'll be making forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the Securities and Exchange Commission to learn more about these risks and uncertainties.
So we just hosted our annual conference Ferment and all that's geared towards our customers, understanding why customers are choosing Ginkgo is important to our investors. And so we're going to spend some time today recapping some of the themes from that event. As usual, we'll end with a Q&A session, and I'll take questions from analysts, investors and the public. You can submit those questions to us in advance via Twitter #Gingkoresults or e-mail at [email protected]. All right. Over to you,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)